Docetaxel, Cisplatin, and 5‐Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma

Docetaxel, cisplatin, and 5‐fluorouracil (DCF) significantly improved overall survival in metastatic gastroesophageal adenocarcinoma (GEA). The aim of this study was to assess efficacy of DCF regimen as perioperative chemotherapy compared with surgery alone in patients with resectable GEA. We identi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Med
Auteurs principaux: Fiteni, Frédéric, Paget‐Bailly, Sophie, Messager, Mathieu, N'Guyen, Thierry, Lakkis, Zaher, Mathieu, Pierre, Lamfichekh, Najib, Picard, Alain, Benzidane, Bilell, Cléau, Denis, Bonnetain, Franck, Borg, Christophe, Mariette, Christophe, Kim, Stefano
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2016
Sujets:
Clinical Cancer Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5119963/
https://ncbi.nlm.nih.gov/pubmed/27726290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.885
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires